Systematic literature review and evaluation of patient reported outcome measures (PROMs) for asthma and related allergic diseases

Primary Care Respiratory Journal

Volumn 21, Issue 4, 2012, Pages 455-458

  Worth, Allison ^a   Hammersley, Victoria S ^a   Nurmatov, Ulugbek ^a   Sheikh, Aziz ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Allergy; Asthma; Patient reported outcome measures

Indexed keywords

ALLERGIC DISEASE; ARTICLE; ASTHMA; DATA ANALYSIS; DATA SYNTHESIS; DISEASE ASSOCIATION; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; QUALITY CONTROL; SYSTEMATIC REVIEW;

ADULT; ASTHMA; CHILD; HUMANS; HYPERSENSITIVITY; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84870903781     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2012.00084     Document Type: Article

References (37)

1. Smith S, Cano S, Lamping D, et al. Patient-Reported Outcome Measures (PROMs) for routine use in treatment centres: recommendations based on a review of the scientific evidence. London: Health Services Research Unit, London School of Hygiene and Tropical Medicine, 2005.
2. Bradley C. Feedback on the FDA's February 2006 draft guidance on Patient Reported Outcome (PRO) measures from a developer of PRO measures. Health and Quality of Life Outcomes 2006;4:78. http://dx.doi.org/10.1186/1477-7525-4-78
3. Black N, Jenkinson C. Measuring patients' experiences and outcomes. BMJ 2009;339:b2495. http://dx.doi.org/10.1136/bmj.b2495
4. Department of Health (DH). Guidance on the routine collection of Patient Reported Outcome Measures (PROMs). London: DH, 2008.
5. Medical Research Council (MRC). Patient Reported Outcome Measures (PROMs): identifying UK research priorities. London: MRC, 2009.
6. Appleby J. PROMs: Counting what matters most to patients. In: The King's Fund Blog, 9 February 2009.
7. Department of Health (DH). High Quality Care for All: NHS next stage review final report. London: DH, 2008.
8. Devlin N, Parkin D, Browne J. Using the EQ-5D as a performance measurement tool in the NHS. Discussion paper 09/03. London: Department of Economics, City University, 2009.
9. Greenhalgh J. The application of PROs in clinical practice: what are they, do they work and why? Qual Life Res 2009;18:115-23. http://dx.doi.org/10.1007/s11136-008-9430-6
10. Devlin N, Appleby J. Getting the most out of PROMs. Putting health outcomes at the heart of NHS decision-making. London: The King's Fund, 2010.
11. Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr AJ. The routine use of patient reported outcome measures in healthcare settings. BMJ 2010;340:c186. http://dx.doi.org/10.1136/bmj.c186
12. Browne J, Jamieson L, Lawsey J, et al. Patient Reported Outcome Measures (PROMs) in elective surgery. Report to the Department of Health. London: Health Services Research Unit, London School of Hygiene and Tropical Medicine, 2007.
13. Appleby J, Devlin N. Measuring success in the NHS. Using patient-assessed health outcomes to manage performance of healthcare providers. London: The King's Fund, 2004.
14. Redelmeier D, Guyatt G, Goldstein R. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol 1996;49(11):1215-9. http://dx.doi.org/10.1016/S0895-4356(96)00206-5
15. Flokstra-de Blok BM, DunnGalvin A, Vlieg-Boerstra BJ, et al. Development and validation of the self-administered Food Allergy Quality of Life Questionnaire for adolescents. J Allergy Clin Immunol 2008;122(1):139-44. http://dx.doi.org/10.1016/j.jaci.2008.05.008
16. Flokstra-de Blok BM, DunnGalvin A, Vlieg-Boerstra BJ, et al. Development and validation of a self-administered Food Allergy Quality of Life Questionnaire for children. Clin Exp Allergy 2009;39(1):127-37. http://dx.doi.org/10.1111/j.1365-2222.2008.03120.x
17. Flokstra-de Blok BM, van der Meulen GN, Dunngalvin A, et al. Development and validation of the Food Allergy Quality of Life Questionnaire-Adult Form (FAQLQAF). Allergy 2009;64:1209-17. http://dx.doi.org/10.1111/j.1398-9995.2009.01968.x
18. Coulter A, Ellins J. Effectiveness of strategies for informing, educating and involving patients. BMJ 2007;335:24-7. http://dx.doi.org/10.1136/bmj.39246.581169.80
19. Scottish Medical and Scientific Advisory Committee. Review of Allergy Services in Scotland. Edinburgh: Scottish Government Directorates, 2009.
20. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004;34(4):520-6. http://dx.doi.org/10.1111/j.1365-2222.2004.1935.x
21. Anandan C, Gupta R, Simpson CR, Fischbacher C, Sheikh A. Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases. J R Soc Med 2009;102(10):431-42. http://dx.doi.org/10.1258/jrsm.2009.090027
22. House of Lords Science and Technology Committee. Allergy. 6th report of session 2006-2007. London: The Stationery Office, 2007.
23. Lewis-Jones MS, Finlay AY, Dykes PJ. The infants' dermatitis quality of life index. Br J Dermatol 2001;144(1):104-10. http://dx.doi.org/10.1046/j.1365-2133.2001.03960.x
24. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47(2):76-83. http://dx.doi.org/10.1136/thx.47.2.76
25. Juniper E, Riis B, Juniper B. Development and validation of an electronic version of the Rhinoconjunctivitis Quality of life Questionnaire. Allergy 2007;62:1091-3. http://dx.doi.org/10.1111/j.1398-9995.2007.01370.x
26. Elberink JN, De Monchy JG, Golden D, Brouwer J-L, Guyatt GH, Dubois AE. Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol 2002;109:162-70. http://dx.doi.org/10.1067/mai.2002.120552
27. Charman C, Venn A, Williams H. The Patient-Oriented Eczema Measure. Development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol 2004;140:1513-19. http://dx.doi.org/10.1001/archderm.140.12.1513
28. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008;159(5):997-1035.
29. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol 2001;10:11-18. http://dx.doi.org/10.1034/j.1600-0625.2001.100102.x
30. Roberts G, Hurley C, Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease. J Allergy Clin Immunol 2003;111(3):491-7. http://dx.doi.org/10.1067/mai.2003.138
31. Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: Chronic Urticaria Quality of Life Questionnaire (CU-QoL). Allergy 2005;60(8):1073-8. http://dx.doi.org/10.1111/j.1398-9995.2005.00833.x
32. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6):473-83. http://dx.doi.org/10.1097/00005650-199206000-00002
33. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208. http://dx.doi.org/10.1016/0168-8510(90)90421-9
34. Juniper E, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:77-83. http://dx.doi.org/10.1111/j.1365-2222.1991.tb00807.x
35. Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med/Public Library of Science 2009;6(7):e1000097.
36. Fitzpatrick R, Davey C, Buxton M, Jones D. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998;2(14).
37. Pesudovs K, Burr JM, Harley C, Elliott DB. The development, assessment, and selection of questionnaires. Optom Vis Sci 2007;84(8):663-74. http://dx.doi.org/10.1097/OPX.0b013e318141fe75